You are here:
USE OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING AND TOXICOKINETICS/TOXICODYNAMICS (TK/TD) FOR SENSITIVE POPULATIONS AND LIFESTAGES.
Citation:
BARTON, H. A. USE OF PHYSIOLOGICALLY-BASED PHARMACOKINETIC (PBPK) MODELING AND TOXICOKINETICS/TOXICODYNAMICS (TK/TD) FOR SENSITIVE POPULATIONS AND LIFESTAGES. Presented at International Life Sciences Institute Annual Meeting, Cancun, MEXICO, January 22 - 24, 2007.
Impact/Purpose:
Populations and lifestages may have differential sensitivity due to a combination of differences in exposure, how the body handles the chemical (toxicokinetics)and how the body responds to it (toxicodynamics).
Description:
Populations and lifestages may have differential sensitivity due to a combination of differences in exposure, how the body handles the chemical (toxicokinetics)and how the body responds to it (toxicodynamics).
URLs/Downloads:
Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling and Toxicokinetics/Toxicodynamics (TK/TD) for Sensitive Populations and Lifestages. (PDF, NA pp, 9 KB, about PDF)Use of Physiologically-Based Pharmacokinetic (PBPK) Modeling and Toxicokinetics/Toxicodynamaics (TK/Td) for Sensitive Populations and Lifestages (PDF, NA pp, 496 KB, about PDF)
Record Details:
Record Type:DOCUMENT( PRESENTATION/ ABSTRACT)
Product Published Date:11/23/2007
Record Last Revised:12/03/2008
OMB Category:Other
Record ID:
162684